Panagora Asset Management Inc Adaptive Biotechnologies Corp Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$25.17 - $36.85 $247,672 - $362,604	-9,840 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$30.02 - $39.87 $201,224 - $267,248	6,703 Added 213.68%	9,840 $334,000
Q2 2021 Aug 11, 2021	BUY	$32.22 - $44.59 $10,954 - $15,160	340 Added 12.16%	3,137 $128,000
Q1 2021 May 12, 2021	BUY	$37.26 - $67.74 $104,216 - $189,468	2,797 New	2,797 $113,000
Q3 2020 Nov 13, 2020	SELL	$35.79 - $48.81 $528,224 - $720,386	-14,759 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $368,237 - $714,040	14,759 New	14,759 $714,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.